Hinge Health Inc. shares reached an all-time intraday high of $93.37 on Friday, extending a rally that has lifted the stock 60.55% over the past year.
The digital musculoskeletal health specialist reported second-quarter revenue of $212.8 million, a 53% increase from the prior-year period, while operating income more than doubled to $62 million. Earnings per share came in at $0.59, surpassing the $0.13 consensus estimate.
Operating margins expanded to 29%, up from 19% a year earlier, reflecting improved operational efficiency. Full-year 2026 revenue and profit guidance was raised following the results. The company also reported revenue growth of nearly 50% over the trailing twelve months.
Hinge Health’s market capitalization now stands at $7.25 billion. Analysts have responded with upward revisions to price targets: Citizens raised its target to $107 with a Market Outperform rating, Truist Securities lifted its target to $112, and Stifel increased its target to $96.
Strategic expansion continued with the $105 million acquisition of Cylinder Health, a move into gastrointestinal health. The company’s AI-driven ProPicks tool has cited historical gains of 231.5% for Siemens Energy and 189% for Sandisk, underscoring its data-driven approach to stock selection.
